The Weekly Litigation News Digest is now live. Subscribe now

Purification Of Iduronate-2-Sulfatase - EP2867245

The patent EP2867245 was granted to Shire Human Genetic Therapies on Sep 12, 2018. The application was originally filed on Jun 28, 2013 under application number EP13809853A. The patent is currently recorded with a legal status of "Revoked".

EP2867245

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP13809853A
Filing Date
Jun 28, 2013
Status
Revoked
Jun 24, 2024
Publication Date
Sep 12, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFJun 12, 2019HGFADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004229250
DESCRIPTIONWO2011163649
INTERNATIONAL-SEARCH-REPORTUS6096555
INTERNATIONAL-SEARCH-REPORTUS7323553
INTERNATIONAL-SEARCH-REPORTUS7541164
INTERNATIONAL-SEARCH-REPORTUS8128925
INTERNATIONAL-SEARCH-REPORTWO2011044542
OPPOSITIONEP2723369
OPPOSITIONKR101158673B
OPPOSITIONUS2004229250
OPPOSITIONWO2012177020
OPPOSITIONWO2014005014
OPPOSITIONWO2014005019
SEARCHUS5728381
SEARCHWO2004062592
SEARCHWO2011044542
SEARCHWO2012177020

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents